David Fuglsang-Damgaard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
David Fuglsang-Damgaard has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Anette Marie Hammerum
National Reference Laboratory for Antimicrobial Resistance, Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark
2 shared publications Esad Dzajic
Clinical Diagnostic Department, Clinical Microbiology, Hospital South West Jutland, University Hospital of Southern Denmark, Esbjerg, Denmark
2 shared publications- Frank Hansen
Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark
2 shared publications Agnieszka Barbara Olsén
Department of Clinical Microbiology, Herlev and Gentofte Hospital – University Hospital, Herlev, Denmark
1 shared publicationAnette M. Hammerum
Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark
1 shared publication- Anna Emilie Henius
Department of Microbiology and Infection Control, Statens Serum Institut, Copenhagen, Denmark
1 shared publication
Latest Publications
- Open Access
- 6 October 2026
- Published by IOP Publishing in Journal of Breath Research
- Vol. 20 (4) , 041002
Diagnosing pathogenic DNA from Pneumocystis jirovecii in exhaled breath condensate: a feasibility study
Pathogen identification in pneumonia is achieved in less than 25% of cases. Diagnosis of Pneumocystis pneumonia relies on a multimodal approach combining clinical, radiological, and immunological assessment with microbiological confirmation, most often by polymerase chain reaction. However, the method cannot reliably distinguish between active infection and colonization because of limited assay standardization and lack of universally accepted interpretive criteria. This pilot study explored whether Pneumocystis jirovecii DNA could be detected in patients with suspected infection (PcP) in exhaled breath condensate (EBC). Ten patients with suspected PcP and ten healthy controls provided oral mouthwash (OW) and EBC samples for real-time PCR. P. jirovecii DNA was detected in both OW and EBC in four patients. Ongoing PcP therapy associated with absence of detectable DNA ( p = 0.048). Detecting P. jirovecii DNA in EBC is feasible, supporting its potential as a non-invasive diagnostic and monitoring tool. The study was approved by the North Denmark Regional Committee on Health Research Ethics (Journal number N-20190070).
- 6 October 2026
- Published by IOP Publishing in Journal of Breath Research
- Vol. 20 (4) , 041002
Open AccessDiagnosing pathogenic DNA from Pneumocystis jirovecii in exhaled breath condensate: a feasibility study
Pathogen identification in pneumonia is achieved in less than 25% of cases. Diagnosis of Pneumocystis pneumonia relies on a multimodal approach combining clinical, radiological, and immunological assessment with microbiological confirmation, most often by polymerase chain reaction. However, the method cannot reliably distinguish between active infection and colonization because of limited assay standardization and lack of universally accepted interpretive criteria. This pilot study explored whether Pneumocystis jirovecii DNA could be detected in patients with suspected infection (PcP) in exhaled breath condensate (EBC). Ten patients with suspected PcP and ten healthy controls provided oral mouthwash (OW) and EBC samples for real-time PCR. P. jirovecii DNA was detected in both OW and EBC in four patients. Ongoing PcP therapy associated with absence of detectable DNA ( p = 0.048). Detecting P. jirovecii DNA in EBC is feasible, supporting its potential as a non-invasive diagnostic and monitoring tool. The study was approved by the North Denmark Regional Committee on Health Research Ethics (Journal number N-20190070).
- Top Cited PapersOpen Access
- 29 June 2023
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 28 (26) , 2300291
Increase in invasive group A streptococcal infections and emergence of novel, rapidly expanding sub-lineage of the virulent Streptococcus pyogenes M1 clone, Denmark, 2023
A highly virulent sub-lineage of the Streptococcus pyogenes M1 clone has been rapidly expanding throughout Denmark since late 2022 and now accounts for 30% of the new invasive group A streptococcal infections. We aimed to investigate whether a shift in variant composition can account for the high incidence rates observed over winter 2022/23, or if these are better explained by the impact of COVID-19-related restrictions on population immunity and carriage of group A Streptococcus.
- 29 June 2023
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 28 (26) , 2300291
Top Cited PapersOpen AccessIncrease in invasive group A streptococcal infections and emergence of novel, rapidly expanding sub-lineage of the virulent Streptococcus pyogenes M1 clone, Denmark, 2023
A highly virulent sub-lineage of the Streptococcus pyogenes M1 clone has been rapidly expanding throughout Denmark since late 2022 and now accounts for 30% of the new invasive group A streptococcal infections. We aimed to investigate whether a shift in variant composition can account for the high incidence rates observed over winter 2022/23, or if these are better explained by the impact of COVID-19-related restrictions on population immunity and carriage of group A Streptococcus.
- Open Access
- 1 February 2020
- Published by Microbiology Society in International Journal of Systematic and Evolutionary Microbiology
- Vol. 70 (2) , 1315-1320
Taxonomic reassessment of the genus Pseudocitrobacter using whole genome sequencing: Pseudocitrobacter anthropi is a later heterotypic synonym of Pseudocitrobacter faecalis and description of Pseudocitrobacter vendiensis sp. nov.
The taxonomic status of all Pseudocitrobacter species was re-evaluated by comparative genomics based on whole genome sequencing. As a result, it is obvious that Pseudocitrobacter anthropi is a later heterotypic synonym of Pseudocitrobacter faecalis . In addition, genome-based analysis of strain CPO20170097T, isolated from a patient in northern Denmark was allocated to the genus Pseudocitrobacter . This strain showed significant genotypic and phenotypic differences from P. faecalis and it is proposed that this strain represents a novel species of the genus, for which the name Pseudocitrobacter vendiensis sp. nov. is proposed with the type strain CPO20170097T (=CCUG 73096T=LMG 31042T).
- 1 February 2020
- Published by Microbiology Society in International Journal of Systematic and Evolutionary Microbiology
- Vol. 70 (2) , 1315-1320
Open AccessTaxonomic reassessment of the genus Pseudocitrobacter using whole genome sequencing: Pseudocitrobacter anthropi is a later heterotypic synonym of Pseudocitrobacter faecalis and description of Pseudocitrobacter vendiensis sp. nov.
The taxonomic status of all Pseudocitrobacter species was re-evaluated by comparative genomics based on whole genome sequencing. As a result, it is obvious that Pseudocitrobacter anthropi is a later heterotypic synonym of Pseudocitrobacter faecalis . In addition, genome-based analysis of strain CPO20170097T, isolated from a patient in northern Denmark was allocated to the genus Pseudocitrobacter . This strain showed significant genotypic and phenotypic differences from P. faecalis and it is proposed that this strain represents a novel species of the genus, for which the name Pseudocitrobacter vendiensis sp. nov. is proposed with the type strain CPO20170097T (=CCUG 73096T=LMG 31042T).
- 1 August 2014
- Published by SAGE Publications in Microbial Drug Resistance
- Vol. 20 (4) , 316-324
Characterization of Third-Generation Cephalosporin-Resistant Escherichia coli from Bloodstream Infections in Denmark
The aim of the study was to investigate the molecular epidemiology of 87 third-generation cephalosporin-resistant Escherichia coli (3GC-R Ec) from bloodstream infections in Denmark from 2009. Sixty-eight of the 87 isolates were extended-spectrum beta-lactamase (ESBL) producers, whereas 17 isolates featured AmpC mutations only (without a coexpressed ESBL enzyme) and 2 isolates were producing CMY-22. The majority (82%) of the ESBL-producing isolates in our study were CTX-M-15 producers and primarily belonged to phylogroup B2 (54.4%) or D (23.5%). Further, one of the two CMY-22-producing isolates belonged to B2, whereas only few of the other AmpCs isolates belonged to B2 and D. Pulsed-field gel electrophoresis revealed that both clonal and nonclonal spread of 3GC-R Ec occurred. ST131 was detected in 50% of ESBL-producing isolates. The remaining ESBL-producing isolates belonged to 17 other sequence types (STs), including several other internationally spreading STs ( e.g ., ST10, ST69, and ST405). The majority (93%) of the ESBL-producing isolates and one of the CMY-22-producing isolates were multiresistant. In conclusion, 3GC-R in bacteriaemic E. coli in Denmark was mostly due to ESBL production, overexpression of AmpC, and to a lesser extent to plasmid-mediated AmpC. The worldwide disseminated CTX-M-15-ST131 was strongly represented in this collection of Danish, bacteriaemic E. coli isolates.
- 1 August 2014
- Published by SAGE Publications in Microbial Drug Resistance
- Vol. 20 (4) , 316-324
Characterization of Third-Generation Cephalosporin-Resistant Escherichia coli from Bloodstream Infections in Denmark
The aim of the study was to investigate the molecular epidemiology of 87 third-generation cephalosporin-resistant Escherichia coli (3GC-R Ec) from bloodstream infections in Denmark from 2009. Sixty-eight of the 87 isolates were extended-spectrum beta-lactamase (ESBL) producers, whereas 17 isolates featured AmpC mutations only (without a coexpressed ESBL enzyme) and 2 isolates were producing CMY-22. The majority (82%) of the ESBL-producing isolates in our study were CTX-M-15 producers and primarily belonged to phylogroup B2 (54.4%) or D (23.5%). Further, one of the two CMY-22-producing isolates belonged to B2, whereas only few of the other AmpCs isolates belonged to B2 and D. Pulsed-field gel electrophoresis revealed that both clonal and nonclonal spread of 3GC-R Ec occurred. ST131 was detected in 50% of ESBL-producing isolates. The remaining ESBL-producing isolates belonged to 17 other sequence types (STs), including several other internationally spreading STs ( e.g ., ST10, ST69, and ST405). The majority (93%) of the ESBL-producing isolates and one of the CMY-22-producing isolates were multiresistant. In conclusion, 3GC-R in bacteriaemic E. coli in Denmark was mostly due to ESBL production, overexpression of AmpC, and to a lesser extent to plasmid-mediated AmpC. The worldwide disseminated CTX-M-15-ST131 was strongly represented in this collection of Danish, bacteriaemic E. coli isolates.